Significant risk factors for CIM in breast cancer patients undergoing chemotherapy included Age, BMI, Pathological staging, hemoglobin, Lymphocyte, Diabetes, Liver function, history of radiotherapy, chemotherapy regimen, genetic factors, albumin. The gene discussed is ALB; the disease is diabetes mellitus.